Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Fertil Steril. 2020 Feb 25;113(3):552–560.e3. doi: 10.1016/j.fertnstert.2019.11.008

Table 1. Characteristics at screening for all enrolled male subjects.

Data are presented as the number (%) or median (interquartile range).

Antioxidants (n=85) Placebo (n=86)
Age (years) 34.0 (30.0, 38.0) 34.0 (30.0, 37.0)
Body mass index (kg/m2) 27.8 (24.2, 31.7), n=82 27.6 (24.4, 31.0)
Ethnicity
 Hispanic or Latino 7 (8.2) 5 (5.8)
 Non-Hispanic 72 (84.7) 78 (90.7)
 Unknown 6 (7.1) 3 (3.5)
Race
 White 63 (74.1) 69 (80.2)
 Black 6 (7.1) 7 (8.1)
 Asian 7 (8.2) 2 (2.3)
 American Indian or Alaska Native 1 (12) 1 (12)
 Unknown 8 (9.4) 5 (5.8)
 Mixed Race 0 (0) 2 (2.3)
Abnormal semen parameters
 Single abnormal parameter
  Sperm concentration ≤15 Million/ml 4 (4.7) 5 (5.8)
  Total motility ≤40% 9 (10.6) 10 (11.6)
  Normal morphology# ≤4% 33 (38.8) 29 (33.7)
 >1 abnormal parameters 39 (45.9) 42 (48.8)
Fathered a prior pregnancy^
 Yes 25 (29.4) 38 (44.2)
 No 60 (70.6) 48 (55.8)
Prior infertility treatment and/or surgery
 Yes 25 (29.4) 24 (27.9)
 No 60 (70.6) 62 (72.1)
Duration of infertility (months) 24.0 (18.0, 48.0), n=81 24.0 (15.0, 36.0), n=83
History of smoking
 Never 54 (63.5) 47 (54.7)
 Current 8 (9.4) 11 (12.8)
 Former 23 (27.1) 28 (32.6)
History of alcohol use
 Never 6 (7.1) 4 (4.7)
 Current (in the past year) 72 (84.7) 81 (94.2)
 Former (not in the past year) 7 (8.2) 1 (12)
#

WHO 5th criteria.

^

p<0.05, Wilcoxon’s rank-sum test was used for the continuous variables, and Chi-square or Fisher’s exact test was used for categorical variables. Wilcoxon’s rank-sum test was used to test the distributional difference, instead of mean or median of the two groups

HHS Vulnerability Disclosure